Morgan Stanley’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-41,977
| Closed | -$14K | – | 7037 |
|
|
2018
Q2 | $14K | Sell |
41,977
-32,841
| -44% | -$11K | ﹤0.01% | 6236 |
|
|
2018
Q1 | $113K | Buy |
74,818
+13,010
| +21% | +$19.6K | ﹤0.01% | 5668 |
|
|
2017
Q4 | $88K | Buy |
61,808
+14,021
| +29% | +$20K | ﹤0.01% | 5676 |
|
|
2017
Q3 | $110K | Sell |
47,787
-55,168
| -54% | -$127K | ﹤0.01% | 5547 |
|
|
2017
Q2 | $139K | Buy |
102,955
+2,611
| +3% | +$3.53K | ﹤0.01% | 5503 |
|
|
2017
Q1 | $215K | Sell |
100,344
-86,433
| -46% | -$185K | ﹤0.01% | 5298 |
|
|
2016
Q4 | $823K | Buy |
186,777
+115,486
| +162% | +$509K | ﹤0.01% | 4614 |
|
|
2016
Q3 | $346K | Buy |
71,291
+38,771
| +119% | +$188K | ﹤0.01% | 4742 |
|
|
2016
Q2 | $107K | Sell |
32,520
-314
| -1% | -$1.03K | ﹤0.01% | 5217 |
|
|
2016
Q1 | $116K | Buy |
+32,834
| New | +$116K | ﹤0.01% | 5248 |
|